These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 7691341)
21. Central administration of a nitric oxide synthase inhibitor causes pressor responses via the sympathetic nervous system and the renin-angiotensin system in Wistar rats. Moriguchi S; Ohzuru N; Koga N; Honda K; Saito R; Takano Y; Kamiya H Neurosci Lett; 1998 Apr; 245(2):109-12. PubMed ID: 9605497 [TBL] [Abstract][Full Text] [Related]
22. Effect of LP-805, a releaser of endothelium-derived nitric oxide, on systemic vasodilatation in vivo. Inazu M; Tujitani M Naunyn Schmiedebergs Arch Pharmacol; 1993 Aug; 348(2):178-83. PubMed ID: 8232597 [TBL] [Abstract][Full Text] [Related]
23. Decreased renal haemodynamic response to inhibition of nitric oxide synthase in subtotally nephrectomized rats. Wagner J; Wystrychowski A; Stauss H; Ganten D; Ritz E Pflugers Arch; 1995 Jun; 430(2):181-7. PubMed ID: 7545811 [TBL] [Abstract][Full Text] [Related]
24. N omega-nitro-L-arginine inhibits vasodilations and elevations of both cyclic AMP and cyclic GMP levels in rat aorta induced by calcitonin gene-related peptide (CGRP). Hao H; Fiscus RR; Wang X; Diana JN Neuropeptides; 1994 Feb; 26(2):123-31. PubMed ID: 7513384 [TBL] [Abstract][Full Text] [Related]
25. N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases. Reif DW; McCreedy SA Arch Biochem Biophys; 1995 Jun; 320(1):170-6. PubMed ID: 7540822 [TBL] [Abstract][Full Text] [Related]
26. Role of superoxide and nitric oxide in platelet-activating factor-induced acute lung injury, hypotension, and mortality in rats. Yoshikawa T; Takano H; Yamamoto H; Nakahashi Y; Yamaguchi T; Arimoto T; Kondo M Crit Care Med; 1997 Feb; 25(2):286-92. PubMed ID: 9034266 [TBL] [Abstract][Full Text] [Related]
27. [Hemodynamic effects of sub-chronic NO synthase inhibition in conscious dogs: role of EDRF/NO in muscular exertion]. Puybasset L; Béa ML; Simon L; Ghaleh B; Giudicelli JF; Berdeaux A Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1217-21. PubMed ID: 8572877 [TBL] [Abstract][Full Text] [Related]
28. Nitro-L-arginine analogues. Dose- and time-related nitric oxide synthase inhibition in brain. Traystman RJ; Moore LE; Helfaer MA; Davis S; Banasiak K; Williams M; Hurn PD Stroke; 1995 May; 26(5):864-9. PubMed ID: 7537926 [TBL] [Abstract][Full Text] [Related]
29. Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats. Danielson LA; Conrad KP J Clin Invest; 1995 Jul; 96(1):482-90. PubMed ID: 7542284 [TBL] [Abstract][Full Text] [Related]
30. Nitric oxide synthase in the pig autonomic nervous system in relation to the influence of NG--nitro-L-arginine on sympathetic and parasympathetic vascular control in vivo. Modin A; Weitzberg E; Hökfelt T; Lundberg JM Neuroscience; 1994 Sep; 62(1):189-203. PubMed ID: 7529378 [TBL] [Abstract][Full Text] [Related]
31. Sustained inhibition of nitric oxide by NG-nitro-L-arginine improves myocardial function following ischemia/reperfusion in isolated perfused rat heart. Naseem SA; Kontos MC; Rao PS; Jesse RL; Hess ML; Kukreja RC J Mol Cell Cardiol; 1995 Jan; 27(1):419-26. PubMed ID: 7760362 [TBL] [Abstract][Full Text] [Related]
32. The role of nitric oxide, adrenergic activation and kinin-degradation in blood pressure homeostasis following an acute kinin-induced hypotension. Bjørnstad-Ostensen A; Berg T Br J Pharmacol; 1994 Dec; 113(4):1567-73. PubMed ID: 7889314 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of NO synthase increases the severity of kainic acid-induced seizures in rodents. Penix LP; Davis W; Subramaniam S Epilepsy Res; 1994 Jul; 18(3):177-84. PubMed ID: 7528658 [TBL] [Abstract][Full Text] [Related]
34. Central and peripheral effects of asymmetric dimethylarginine, an endogenous nitric oxide synthetase inhibitor. Jin JS; D'Alecy LG J Cardiovasc Pharmacol; 1996 Sep; 28(3):439-46. PubMed ID: 8877592 [TBL] [Abstract][Full Text] [Related]
35. Effects of inhibition of nitric oxide synthase on systemic arterial pressure and renal vascular resistance in cats. Brown SA Res Vet Sci; 1993 Nov; 55(3):398-400. PubMed ID: 7506838 [TBL] [Abstract][Full Text] [Related]
36. Dose-dependent effects of a nitric oxide biosynthesis inhibitor on hyperdynamic circulation in two models of portal hypertension in conscious rats. Pilette C; Kirstetter P; Sogni P; Cailmail S; Moreau R; Lebrec D J Gastroenterol Hepatol; 1996 Jan; 11(1):1-6. PubMed ID: 8672735 [TBL] [Abstract][Full Text] [Related]
37. Role of nitric oxide in the pancreatic blood flow response to caerulein. Satoh A; Shimosegawa T; Abe T; Kikuchi Y; Abe R; Koizumi M; Toyota T Pancreas; 1994 Sep; 9(5):574-9. PubMed ID: 7528917 [TBL] [Abstract][Full Text] [Related]
38. Role of nitric oxide in glycerol-induced acute renal failure in rats. Maree A; Peer G; Schwartz D; Serban I; Blum M; Wollman Y; Cabili S; Iaina A Nephrol Dial Transplant; 1994; 9 Suppl 4():78-81. PubMed ID: 7528365 [TBL] [Abstract][Full Text] [Related]
39. Nitric oxide synthase inhibitors do not alter functional hyperemia in canine skeletal muscle. Barclay JK; Woodley NE Can J Physiol Pharmacol; 1994 Sep; 72(9):1035-41. PubMed ID: 7531112 [TBL] [Abstract][Full Text] [Related]
40. Vasopressin does not effect hypertension caused by long-term nitric oxide inhibition. Loichot C; Cazaubon C; Grima M; De Jong W; Nisato D; Imbs JL; Barthelmebs M Hypertension; 2000 Feb; 35(2):602-8. PubMed ID: 10679504 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]